Currently, there is no single biomarker accepted for lung cancer early detection, although some are spuriously used, such as neuron-specific enolase (NSE) for small cell lung cancer or cytokeratin for squamous lung cancer. Here, ENO2 is linked to small cell lung carcinoma.